Graziani, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 4.917
AS - Asia 3.778
EU - Europa 3.194
SA - Sud America 753
Continente sconosciuto - Info sul continente non disponibili 169
AF - Africa 115
OC - Oceania 11
Totale 12.937
Nazione #
US - Stati Uniti d'America 4.753
SG - Singapore 1.665
CN - Cina 919
DE - Germania 800
IT - Italia 739
BR - Brasile 622
SE - Svezia 461
VN - Vietnam 338
FR - Francia 320
GB - Regno Unito 180
IE - Irlanda 155
IN - India 133
JP - Giappone 119
ID - Indonesia 103
HK - Hong Kong 102
BD - Bangladesh 94
FI - Finlandia 91
CA - Canada 84
UA - Ucraina 84
RU - Federazione Russa 78
NL - Olanda 56
KR - Corea 52
PL - Polonia 48
AR - Argentina 46
MX - Messico 44
IQ - Iraq 41
TR - Turchia 40
ZA - Sudafrica 40
AT - Austria 36
ES - Italia 27
EC - Ecuador 20
IR - Iran 20
PK - Pakistan 19
VE - Venezuela 19
SA - Arabia Saudita 18
BE - Belgio 17
CI - Costa d'Avorio 16
JO - Giordania 16
CO - Colombia 14
UZ - Uzbekistan 14
LT - Lituania 13
IL - Israele 12
MA - Marocco 12
CL - Cile 11
EG - Egitto 10
RO - Romania 10
AU - Australia 9
CH - Svizzera 9
AE - Emirati Arabi Uniti 8
JM - Giamaica 8
KE - Kenya 8
BG - Bulgaria 7
DZ - Algeria 7
NP - Nepal 7
PE - Perù 7
PH - Filippine 7
TN - Tunisia 7
CU - Cuba 6
GR - Grecia 6
KZ - Kazakistan 6
PY - Paraguay 6
RS - Serbia 6
UY - Uruguay 6
CZ - Repubblica Ceca 5
HR - Croazia 5
HU - Ungheria 5
MD - Moldavia 5
PS - Palestinian Territory 5
PT - Portogallo 5
AL - Albania 4
AZ - Azerbaigian 4
HN - Honduras 4
KH - Cambogia 4
LB - Libano 4
LV - Lettonia 4
MK - Macedonia 4
MY - Malesia 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TH - Thailandia 4
AO - Angola 3
BY - Bielorussia 3
CR - Costa Rica 3
CY - Cipro 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
NO - Norvegia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BH - Bahrain 2
EU - Europa 2
KW - Kuwait 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
Totale 12.754
Città #
Singapore 945
San Jose 579
Ashburn 573
Chandler 472
Beijing 198
Rome 174
New York 169
Hefei 151
Dublin 146
Ho Chi Minh City 119
Los Angeles 118
Tokyo 108
St Louis 107
Lauterbourg 106
The Dalles 106
Milan 95
Hong Kong 91
Jakarta 90
Hanoi 89
Frankfurt am Main 78
Marseille 64
San Mateo 63
São Paulo 61
Munich 59
Jacksonville 57
Boston 56
Nanjing 56
Moscow 50
Dallas 49
Seoul 49
Ann Arbor 45
Santa Clara 44
Wilmington 43
Helsinki 42
Kent 42
Buffalo 40
Houston 39
London 39
Nürnberg 36
Nuremberg 34
Princeton 30
Seattle 30
Warsaw 30
Bremen 29
Chicago 29
Stockholm 29
Atlanta 25
Council Bluffs 25
Orem 24
Paris 24
Phoenix 24
Boardman 23
Cattolica 23
Tukwila 23
Brooklyn 22
Chennai 22
Johannesburg 21
Lappeenranta 21
Montreal 21
Rio de Janeiro 21
Toronto 21
Washington 21
Amsterdam 20
Mexico City 20
Denver 19
Bologna 18
Dearborn 18
Nanchang 18
North Bergen 18
San Francisco 18
Vienna 18
Baghdad 17
Brussels 17
Düsseldorf 17
Haiphong 17
Pune 17
Redwood City 17
Roubaix 17
Tianjin 17
Abidjan 16
Amman 16
Poplar 15
Woodbridge 15
Da Nang 13
Lawrence 13
Mumbai 13
Palermo 13
Tashkent 13
Turku 13
Belo Horizonte 12
Enterprise 12
Las Vegas 12
Manchester 12
Salvador 12
Bexley 11
Guangzhou 11
Guarulhos 11
Naples 11
Newark 11
Brasília 10
Totale 6.588
Nome #
Paradoxical preservation of vascular function in severe obesity 362
Right ventricular-pulmonary artery coupling assessed by two-dimensional strain predicts in-hospital complications in Takotsubo syndrome 332
Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery 223
Effects of bariatric surgery on cardiac remodeling: clinical and pathophysiologic implications 219
Comparison of De-Kay repair versus De Vega suture for functional tricuspid regurgitation: a preliminary experience 210
Cardiovascular risk in obesity: different activation of inflammation and immune system between obese and morbidly obese subjects 207
Endothelial progenitor cells in morbid obesity 202
Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery 199
Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathy 196
Thromboxane production in morbidly obese subjects 194
Prevalence and Clinical Correlates of Cerebrovascular Alterations in Fabry Disease: A Cross-Sectional Study 178
Inflammasome, T Lymphocytes and Innate-Adaptive Immunity Crosstalk: Role in Cardiovascular Disease and Therapeutic Perspectives 175
Chlamydia pneumoniae in coronary atherosclerotic plaques and coronary instability 167
Dysbiosis, gut microbiota modulation and intestinal permeability in recurrent cystitis patients and concomitant gastrointestinal pathologies 167
Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus 166
Infections, immunity and atherosclerosis: pathogenic mechanisms and unsolved questions 166
Cardiovascular involvement in patients affected by multiple myeloma: a comprehensive review of recent advances 163
A multimodal approach to predict prosthesis-patient mismatch in patients undergoing valve-in-valve trans-catheter aortic valve implantation 160
Right Ventricular Hypertrophy, Systolic Function, and Disease Severity in Anderson-Fabry Disease: An Echocardiographic Study 159
Clinical Impact of Heart Team Decisions for Patients With Complex Valvular Heart Disease: A Large, Single-Center Experience 155
Coronary Microvascular Dysfunction Is Associated With a Worse Cardiac Phenotype in Patients With Fabry Disease 154
Heart Team e malattie valvolari: L’importanza di un approccio multidisciplinare 151
Chlamydia pneumoniae in coronary atherosclerotic plaques and coronary instability 150
Response to letter regarding article, "growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery" 147
The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: study protocol for a randomized controlled trial 146
Early Right Heart Chambers Reverse Remodeling in Patients Operated in Adulthood for Congenital Lesions Associated with Right Heart Chambers Enlargement 135
Acute haemodynamic impact of transcatheter aortic valve implantation in patients with severe aortic stenosis 135
Precision medicine versus standard of care for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA): rationale and design of the multicentre, randomised PROMISE trial 134
Right ventricle systolic function and right ventricle-pulmonary artery coupling in patients with severe aortic stenosis and the early impact of TAVI 131
Global longitudinal strain for prediction of mortality in ST-segment elevation myocardial infarction and aortic stenosis patients: two sides of the same coin 129
Right ventricular strain in Anderson-Fabry disease 127
An uplifted destiny for mucopolysaccharidosis type I with heart involvement 125
Early cardiac mechanics abnormalities in patients with mitochondrial diseases 124
The Effects of Granulocyte Colony-Stimulating Factor in Patients with a Large Anterior Wall Acute Myocardial Infarction to Prevent Left Ventricular Remodeling: A 10-Year Follow-Up of the RIGENERA Study 123
Diagnosis and management of peripartum cardiomyopathy and recurrence risk 122
Inflammation across the spectrum of hypertrophic cardiac phenotypes 121
Performance, clinical outcomes and implementation of an original heart valve clinic model 121
Prognostic significance of right ventricular hypertrophy and systolic function in Anderson–Fabry disease 121
Diagnostic role of echocardiography in patients admitted to the emergency room with suspect no-ST-segment elevation acute myocardial infarction 120
Pulmonary congestion assessed by lung ultrasound in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: Prevalence and prognostic implications 119
Echocardiographic left atrial stiffness index predicts high left ventricular filling pressures in patients with acute heart failure: an observational study 118
Valvular heart disease and cardiomyopathy: reappraisal of their interplay 118
When compassionate is appropriate for end-stage aortic valve stenosis? 118
Massive Coronary Microvascular Dysfunction in Severe Anderson-Fabry Disease Cardiomyopathy 116
Right atrial strain in Anderson-Fabry disease 115
Unexpected Left Ventricle Pseudoaneurysm With Unusual Origin: History of a Diseased Annulus Broken Into a Diseased Myocardium 115
Right ventricular strain in Fabry disease: Prognostic implications 114
Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities 113
Association of Cardiac Sarcoidosis and Ulcerative Colitis: A Case Report and a Brief Review of the Literature 112
Transcatheter aortic valve implantation in pure aortic regurgitation: Hemodynamic and echocardiographic findings in bioprosthesis vs. native valve 111
Impact of Impella protected-percutaneous coronary intervention on left ventricle function recovery of patients with extensive coronary disease and poor left ventricular function 110
Trabecular complexity as an early marker of cardiac involvement in Fabry disease 108
Effect of Migalastat on cArdiac Involvement in FabRry Disease: MAIORA study 108
Pregnancy outcome and left ventricular ejection fraction in women with history of myocardial infarction 108
Pulmonary artery sling in a 22-month-old boy with 18q deletion syndrome: A rare but possible association 107
Transthoracic Echocardiography in Assessing Patients with Suspected Infective Endocarditis (TEASE): An Exploratory Study 106
Evolution of Cardiac Damage Staged With Echocardiography in Fabry Disease 106
Right ventricle-pulmonary artery coupling in repaired tetralogy of Fallot with pulmonary regurgitation: Clinical implications 105
Comparative analysis of right ventricular strain in Fabry cardiomyopathy and sarcomeric hypertrophic cardiomyopathy 105
Instability mechanisms in unstable angina according to baseline serum levels of C-reactive protein: The role of thrombosis, fibrinolysis and atherosclerotic burden. 105
Evidence of evolution towards left midventricular obstruction in severe Anderson–Fabry cardiomyopathy 105
Emerging multisystem biomarkers in hereditary transthyretin amyloidosis: a pilot study 103
Impact of Impella protected-percutaneous coronary intervention on left ventricle function recovery of patients with extensive coronary disease and poor left ventricular function 102
Left atrial strain analysis improves left ventricular filling pressures non-invasive estimation in the acute phase of Takotsubo syndrome 102
Telemedicine for adult congenital heart disease patients during the first wave of COVID-19 era: a single center experience 102
Telemedicine for adult congenital heart disease patients during the first wave of COVID-19 era: a single center experience 102
Pregnancy outcome and left ventricular ejection fraction in women with history of myocardial infarction 101
Atypical Thrombosis Following Mitral Transcatheter Edge-to-Edge Repair: Face to Face Between Scar and Clip 101
Evolution and Prognostic Impact of Right Ventricular-Pulmonary Artery Coupling After Transcatheter Aortic Valve Replacement 100
Successful Transcatheter Treatment of Left Pulmonary Artery to Left Atrium Communication Diagnosed in Adulthood 99
Temporal trends of frame expansion and paravalvular leak reduction after transcatheter aortic valve replacement with self-expandable prostheses 98
A Novel Hemodynamic Index Characterizing Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair: The MPF 98
Left atrial structural and functional remodelling in Fabry disease and cardiac amyloidosis: A comparative analysis 96
Evaluation of Adults With Congenital Heart Disease 95
Early Hemodynamic and Structural Impact of Transcatheter Aortic Valve Replacement in Pure Aortic Regurgitation 95
Impact of severe valvular heart disease in adult congenital heart disease patients 93
Management, Flow, and Outcomes of Patients with Aortic Stenosis Followed by a Heart Valve Clinic: The Untold "Behind the Scene" from a High-Volume, Real-World Experience 92
Cardiac Magnetic Resonance Features of Fabry Disease: From Early Diagnosis to Prognostic Stratification 91
Undiagnosed Severe Late Complications of Repaired Tetralogy of Fallot 85
The Heart in Fabry Disease: Mechanisms Beyond Storage and Forthcoming Therapies 83
Treating heart failure with preserved ejection fraction: learning from pulmonary fibrosis 83
An uplifted destiny for mucopolysaccharidosis type I with heart valve involvement 83
Predictors of Clinical Evolution in Prehypertrophic Fabry Disease 82
Early improvement of strain imaging parameters predicts long-term response to sacubitril/valsartan in patients with heart failure with reduced ejection fraction: An observational prospective study 81
Anderson-Fabry's Disease: A Rare but Treatable Case of Fever of Unknown Origin 80
ECG-based score estimates the probability to detect Fabry Disease cardiac involvement 79
Right ventricular to pulmonary artery coupling and prognosis in transthyretin cardiac amyloidosis 78
Non-invasive imaging of ventricular-atrial fistulization secondary to infective rupture of caseous calcification of the mitral annulus 78
Pregnancy in hypertrophic cardiomyopathy: New data, old questions 77
Severe silent myocardial ischemia during echocardiographic examination in a patient during cardiac screening for a kidney transplant intervention 77
Rationale for the Use of Pirfenidone in Heart Failure With Preserved Ejection Fraction 76
Myocardial infarction with non-obstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry disease 75
Généreux staging classification in predicting left ventricular reverse remodeling after intervention for severe aortic valve regurgitation 74
An unusual case of mitral valve chordal rupture 74
Modified Warden procedure in adult with partial anomalous pulmonary venous connection after previous atrial septal defect repair 74
Dynamic modulation of coronary arterio-venous communications 73
Subclinical dysfunction of remote myocardium is related to high NT-proBNP and affects global contractility at follow-up, independently of infarct area 72
Prognostic Implications of the Extent of Cardiac Damage in Patients With Fabry Disease 71
Echocardiography in Anderson-Fabry Disease 69
Potential resistance to SARS-CoV-2 infection in lysosomal storage disorders 65
Totale 12.317
Categoria #
all - tutte 55.309
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.309


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022489 0 22 4 32 47 13 8 97 22 44 101 99
2022/20231.445 160 152 119 203 66 167 95 138 144 112 67 22
2023/2024977 40 240 49 59 51 178 42 35 34 42 90 117
2024/20252.208 35 59 150 74 160 67 82 92 324 195 585 385
2025/20265.833 818 233 346 671 804 330 961 291 376 501 322 180
2026/2027697 279 418 0 0 0 0 0 0 0 0 0 0
Totale 12.937